John T. Bigalke CPA serves as Independent Director of the Company. He has served as the Chief Executive Officer of Second Half Healthcare Advisors, a healthcare strategy firm in Orlando, Florida, since its founding by Mr. Bigalke in 2016. Previously, he was with Deloitte USA LLP from 1998 to 2016, including serving as Vice Chairman and National Industry Leader for the Health Care and Life Science Practice from 2002 until 2012 and Vice Chairman and Senior Partner, Global Health Care Practice from 2012 to 2016. Mr. Bigalke currently serves on the Board of Directors of Progenity, Inc., a privately held biotechnology company (Audit Committee Chair and member of Nominating and Governance Committee) and AdventHealth ((non-voting) member of Audit Committee, Finance and Strategy Committee and Risk and Corporate Responsibility Committee). He also serves on the Advisory Board of Concord Healthcare Management Services, LLC and Vaxcare, Inc. (Chair). He previously served on the boards of Deloitte USA, LLP (Chair of Audit and Finance committee and member of Executive Committee, Risk Committee and Strategy Committee) and the Healthcare Financial Management Association (Strategy Committee and Executive Committee). Mr. Bigalke obtained a bachelor’s degree from Clemson University and completed the Leadership Development Program at Columbia University Graduate School of Business and the Executive Leadership Program at the Wharton School of the University of Pennsylvania. Mr. Bigalke is a licensed Certified Public Accountant.
John Bigalke is 65, he's been the Independent Director of Premier Inc since 2019. There are 3 older and 20 younger executives at Premier Inc. The oldest executive at Premier Inc is Marvin O'Quinn, 67, who is the Director.
John's mailing address filed with the SEC is C/O PREMIER, INC., 13034 BALLANTYNE CORPORATE PLACE, CHARLOTTE, NC, 28277.
Over the last 11 years, insiders at Premier Inc have traded over $25,805,748 worth of Premier Inc stock and bought 58,600 units worth $1,642,100 . The most active insiders traders include Marc D Miller, Craig S. Mc Kasson et Michael J. Alkire. On average, Premier Inc executives and independent directors trade stock every 38 days with the average trade being worth of $320,590. The most recent stock trade was executed by Andy Brailo on 6 September 2024, trading 21,390 units of PINC stock currently worth $436,998.
as a leading national healthcare solutions organization, premier, inc. collaborates with healthcare organizations to improve supply chain management, decrease healthcare costs, integrate data and improve the health of communities. as an industry leader, premier has created one of the most comprehensive database of actionable data, best practices and cost reduction strategies. we enable our members to collaborate easily and efficiently improve their quality outcomes, while reducing costs. by engaging members and revealing new opportunities, we empower our alliance to improve performance like no one else in healthcare can.
Premier Inc executives and other stock owners filed with the SEC include: